LivaNova’s Perceval Sutureless Aortic Heart Valve Approved in Japan

June 11, 2018 by Website Admin in

LivaNova today announced that Japan’s Ministry of Health, Labour and Welfare has approved the Company’s Perceval® sutureless aortic heart valve to treat aortic valve disease.

Tweet

Share

Pin it

Previous StoryMoleculin’s Breakthrough Discovery of a New Molecule for Cancer Treatment Advances to Development Agreement with the University of Iowa Next StoryMoleculin Targets accelerated FDA approval of WP1732; Pursues Development for Ocular Tumors